Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 18/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MITF | O75030 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28722470 | 0.86 | CD38 (0.58) | CD38KDM4ETSHRMAPK1ATM | |
| SCHEMBL31124712 | 0.86 | CD38 (0.58) | CD38KDM4ETSHRMAPK1ATM | |
| SCHEMBL28722358 | 0.81 | CD38 (0.55) | CD38 | |
| SCHEMBL28938322 | 0.79 | CD38 (0.64) | CD38 | |
| SCHEMBL28723003 | 0.79 | CD38 (0.54) | CD38 | |
| SCHEMBL29495194 | 0.77 | CD38 (0.47) | CD38KDM4ETSHRMAPK1ATM | |
| SCHEMBL29495167 | 0.76 | CD38 (0.53) | CD38KDM4ETSHRMAPK1ATM | |
| SCHEMBL29495178 | 0.72 | — | — | |
| SCHEMBL22932812 | 0.70 | CD38 (1.00) | CD38 | |
| SCHEMBL29696396 | 0.70 | CD38 (1.00) | CD38 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431323-A | Heterobicyclic amides as CD38 inhibitors | 贝林格尔·英格海姆国际有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-114423753-B | Heterobicyclic amides as CD38 inhibitors | 里邦医疗公司 | 2024-09-17 | — | — | CN | disclosed |
| CN-114423753-A | Heterobicyclic amides as CD38 inhibitors | 里邦医疗公司 | 2022-04-29 | — | — | CN | disclosed |